Identification of ABCC3 and its isoforms as potential biomarker in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Identification of ABCC3 and its isoforms as potential biomarker in hepatocellular carcinoma

Published:2023-12-11 Issue: Volume: Page:1-10
ISSN:1537-6516
Container-title:Toxicology Mechanisms and Methods
language:en
Short-container-title:Toxicology Mechanisms and Methods

Author:

Zertuche-Martínez Cecilia¹,Velázquez-Enríquez Juan Manuel¹,González-García Karina¹,Baltiérrez-Hoyos Rafael²,Carrasco-Torres Gabriela³,García-Román Rebeca⁴,Romero-Díaz Roberto Iván⁵,Pérez-Hernández José Luis⁶,Muriel Pablo⁷,Villa-Treviño Saúl⁸,Arellanes-Robledo Jaime⁹,Vásquez-Garzón Verónica Rocío²

Affiliation:

1. Faculty of Medicine and Surgery, Laboratory of Fibrosis and Cancer, ‘Benito Juarez’ Autonomous University of Oaxaca-UABJO, Oaxaca, Mexico

2. CONACYT-Faculty of Medicine and Surgery, Autonomous University “Benito Juarez” of Oaxaca-UABJO, Oaxaca, Mexico

3. Centre for Research in Applied Science and Advanced Technology, Morelos Unit, National Polytechnic Institute, Atlacholoaya, Mexico

4. Institute of Public Health, Universidad Veracruzana, Xalapa, Mexico

5. General Hospital Zone 1, Mexican Social Security Institute-IMSS, Oaxaca, Mexico

6. Gastroenterology Services, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City, Mexico

7. Department of Pharmacology, Laboratory of Experimental Hepatology, Center for Research and Advanced Studies of the National Polytechnic Institute – CINVESTAV-IPN, Mexico City, Mexico

8. Department of Cell Biology, Center for Research and Advanced Studies of the National Polytechnic Institute – CINVESTAV-IPN, Mexico City, Mexico

9. CONACYT-Laboratory of Liver Diseases, National Institute of Genomic Medicine – INMEGEN, Mexico City, Mexico

Funder

SS/IMSS/ISSSTE-CONACYT

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Toxicology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15376516.2023.2294475

Reference44 articles.

1. ABCC3 is a novel target for the treatment of pancreatic cancer

2. Molecular alterations that precede the establishment of the hallmarks of cancer: An approach on the prevention of hepatocarcinogenesis

3. Role of the Drug Transporter ABCC3 in Breast Cancer Chemoresistance

4. Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis

5. The transmembrane transporter ABCC3 participates in liver cancer progression and is a potential biomarker